Human tumor genomics and zebrafish modeling identify SPRED1 loss as a driver of mucosal melanoma

Melanomas originating from mucosal surfaces have low mutation burden, genomic instability, and poor prognosis. To identify potential driver genes, we sequenced hundreds of cancer-related genes in 43 human mucosal melanomas, cataloging point mutations, amplifications, and deletions. The gene, which e...

Full description

Saved in:
Bibliographic Details
Published in:Science (American Association for the Advancement of Science) 2018-11, Vol.362 (6418), p.1055-1060
Main Authors: Ablain, Julien, Xu, Mengshu, Rothschild, Harriet, Jordan, Richard C, Mito, Jeffrey K, Daniels, Brianne H, Bell, Caitlin F, Joseph, Nancy M, Wu, Hong, Bastian, Boris C, Zon, Leonard I, Yeh, Iwei
Format: Article
Language:eng
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Melanomas originating from mucosal surfaces have low mutation burden, genomic instability, and poor prognosis. To identify potential driver genes, we sequenced hundreds of cancer-related genes in 43 human mucosal melanomas, cataloging point mutations, amplifications, and deletions. The gene, which encodes a negative regulator of mitogen-activated protein kinase (MAPK) signaling, was inactivated in 37% of the tumors. Four distinct genotypes were associated with loss. Using a rapid, tissue-specific CRISPR technique to model these genotypes in zebrafish, we found that functions as a tumor suppressor, particularly in the context of mutations. knockdown caused MAPK activation, increased cell proliferation, and conferred resistance to drugs inhibiting KIT tyrosine kinase activity. These findings provide a rationale for MAPK inhibition in SPRED1-deficient melanomas and introduce a zebrafish modeling approach that can be used more generally to dissect genetic interactions in cancer.
ISSN:0036-8075
1095-9203